Elcelyx Overview

  • Founded
  • 2010
Founded
  • Status
  • Out of Business
  • Employees
  • 19
Employees
  • Latest Deal Type
  • Out of Business

Elcelyx General Information

Description

Developer of nutrient based products designed to treat diabetes, weight management and obesity-related metabolic disorders. The company's products include Lovidia(TM) and NewMet(TM) amplifies the release of hormones, enabling patients to improve glucose metabolism without systemic side effects.

Contact Information

Website
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Food Products
Primary Office
  • 11975 El Camino Real
  • Suite 305
  • San Diego, CA 92130
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Elcelyx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business 17-Jan-2020 000.00 Completed Out of Business
6. Later Stage VC 07-Nov-2018 00000 000.00 Completed Generating Revenue
5. Later Stage VC (Series E) 01-Oct-2015 0000 000.00 00000 Completed Generating Revenue
4. Later Stage VC (Series D) 18-Feb-2015 00.000 000.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 24-Feb-2014 000.00 000.00 00000 Completed Generating Revenue
2. Early Stage VC (Series B) 20-Dec-2012 $21.1M $23.1M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 18-Mar-2010 $2M $2M 00.000 Completed Generating Revenue
To view Elcelyx’s complete valuation and funding history, request access »

Elcelyx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series D 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series C1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B1 2,917,930 $0.000100 $0.34 $4.29 $4.29 1x $3.51 8.93%
Series A1 616,109 $0.000100 $0.13 $1.76 $1.76 1x $1.76 1.54%
To view Elcelyx’s complete cap table history, request access »

Elcelyx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of nutrient based products designed to treat diabetes, weight management and obesity-related metabolic disorde
Biotechnology
San Diego, CA
19 As of 2015
000.00
00000000 00 000.00

00000000

t. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pari
000000000000000
San Diego, CA
00 As of 0000
00000
000000000 00000

00000000

r adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad min
0000 00000000
Boston, MA
000 As of 0000
00.000
000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Elcelyx Competitors (24)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Metacrine Venture Capital-Backed San Diego, CA 00 00000 000000000 00000
00000000 000000000 Venture Capital-Backed Boston, MA 000 00.000 000000000 00.000
0000000 Venture Capital-Backed Boston, MA 00 00000 0000000000 0 00000
00000 000000 Venture Capital-Backed New York, NY 000.00 0000000000 0 000.00
000000000 00000000 Corporation Pasadena, CA 000 00.000 000000 - 000 00.000
You’re viewing 5 of 24 competitors. Get the full list »

Elcelyx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial